HEART TRANSPLANTATION AND COVID-19 IN THE EARLY POSTOPERATIVE PERIOD IN HYPERTROPHIC CARDIOMYOPATHY: A CLINICAL CASE

被引:0
作者
Zaynetdinov, M. R. [1 ]
Mukharyamov, M. N. [1 ,2 ]
Dzhordzhikiya, R. K. [1 ,2 ]
Vagizov, I. I. [2 ]
Miroshnichenko, M. A. [2 ]
Abdulyanov, I., V [2 ]
Khamzin, R. R. [2 ]
Abdulganieva, D., I [1 ,3 ]
Dyakova, E., V [3 ]
Bayalieva, A. Zh [1 ]
Gizatullina, N. F. [1 ,2 ]
Stekolshchikova, N. Yu [2 ]
Minnullin, M. M. [3 ]
Khairullin, R. N. [2 ]
机构
[1] Kazan State Med Univ, Kazan, Russia
[2] Interreg Clin Diagnost Ctr, Kazan, Russia
[3] Republican Clin Hosp, Kazan, Russia
来源
VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV | 2022年 / 24卷 / 02期
关键词
hypertrophic cardiomyopathy; heart transplantation; COVID-19; CARDIAC TRANSPLANTATION; DIAGNOSIS;
D O I
10.15825/1995-1191-2022-2-58-64
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Hypertrophic cardiomyopathy (HCM) is a disease that is usually unresponsive to conservative pathogenetic therapy. It does not have clearly developed surgical correction algorithms. Heart transplantation (HTx) is the sole therapeutic option when drug therapy is ineffective and surgical reduction of hypertrophic myocardium is not feasible. There are only sporadic reports in the literature about HTx for HCM. The novel coronavirus disease 2019 (COVID-19) pandemic has significantly affected the work of cardiac surgical units and, in particular, organ transplantation activities. This paper presents a clinical case of an HCM patient who underwent HTx, complicated by COVID-19 infection in the early postoperative period.
引用
收藏
页码:58 / 64
页数:7
相关论文
共 14 条
[1]   Survival After Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy [J].
Batzner, Angelika ;
Pfeiffer, Barbara ;
Neugebauer, Anna ;
Aicha, Diaa ;
Blank, Christoph ;
Seggewiss, Hubert .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (24) :3087-3094
[2]  
Bo ckeria LA A., 2013, ANN SURG, V5, P5
[3]   Effectiveness of Extended Myectomy in Patients With Hypertrophic Cardiomyopathy With Midventricular Obstruction [J].
Bogachev-Prokophiev, A. V. ;
Zheleznev, S. I. ;
Fomenko, M. S. ;
Sharifulin, R. M. ;
Afanasyev, A. V. ;
Malakhova, O. Yu. ;
Karaskov, A. M. .
KARDIOLOGIYA, 2017, 57 (05) :38-43
[4]   Hypertrophic cardiomyopathy in elderly: causes, diagnostic and treatment approaches [J].
Chumakova, O. S. .
TERAPEVTICHESKII ARKHIV, 2020, 92 (09) :63-69
[5]   Cardiac transplantation for hypertrophic cardiomyopathy: A valid therapeutic option [J].
Coutu, M ;
Perrault, LP ;
White, M ;
Pelletier, GB ;
Racine, N ;
Poirier, NC ;
Carrier, M .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2004, 23 (04) :413-417
[6]   2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC) [J].
Elliott, Perry M. ;
Anastasakis, Aris ;
Borger, Michael A. ;
Borggrefe, Martin ;
Cecchi, Franco ;
Charron, Philippe ;
Hagege, Albert Alain ;
Lafont, Antoine ;
Limongelli, Giuseppe ;
Mahrholdt, Heiko ;
McKenna, William J. ;
Mogensen, Jens ;
Nihoyannopoulos, Petros ;
Nistri, Stefano ;
Pieper, Petronella G. ;
Pieske, Burkert ;
Rapezzi, Claudio ;
Rutten, Frans H. ;
Tillmanns, Christoph ;
Watkins, Hugh .
EUROPEAN HEART JOURNAL, 2014, 35 (39) :2733-+
[7]  
[Габрусенко С.А. Gabrusenko S.A.], 2021, [Российский кардиологический журнал, Russian Journal of Cardiology, Rossiiskii kardiologicheskii zhurnal], V26, P269, DOI 10.15829/1560-4071-2021-4541
[8]  
KaoBa B, 2017, KI ACED, V95, P1061
[9]   Cardiac Transplantation in Patients With Hypertrophic Cardiomyopathy [J].
Kato, Tomoko S. ;
Takayama, Hiroo ;
Yoshizawa, Saeko ;
Marboe, Charles ;
Schulze, P. Christian ;
Farr, Maryjane ;
Naka, Yoshifumi ;
Mancini, Donna ;
Maurer, Mathew S. .
AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (04) :568-574
[10]  
[Хитрова Марина Эркиновна Khitrova Marina Erkinovna], 2017, [Креативная кардиология, Kreativnaya kardiologiya], V11, P337, DOI 10.24022/1997-3187-2017-11-4-337-347